Market Overview

The global external defibrillators market reached USD 3.6 Billion in 2024 and is projected to reach USD 6.7 Billion by 2033, growing at a CAGR of 6.87% from 2025 to 2033. This growth is driven by the rising prevalence of cardiovascular diseases, expanding aging population, increasing government initiatives, and continuous technological advancements. The market encompasses product types such as manual external defibrillators, automated external defibrillators (semi-automated and fully automated), and wearable cardioverter defibrillators, serving diverse end users across hospitals, pre-hospitals, public access markets, alternate care, and home healthcare. For more details, visit the External Defibrillators Market

Study Assumption Years

  • Base Year: 2024
  • Historical Year/Period: 2019-2024
  • Forecast Year/Period: 2025-2033

External Defibrillators Market Key Takeaways

  • The global external defibrillators market size was USD 3.6 Billion in 2024.
  • The market is forecasted to grow at a CAGR of 6.87% during 2025-2033.
  • The forecast period for the market is from 2025 to 2033.
  • Major growth drivers include the widespread prevalence of out-of-hospital cardiac arrest (OHCA), a leading cause of adult mortality.
  • Significant rise in hypertension, diabetes, and obesity due to lifestyle changes is increasing heart attack and stroke risks.
  • Modern external defibrillators are cost-effective, easy to operate, and safe, aided by ongoing technological advancements.
  • North America holds a dominant market share due to advanced healthcare technologies and favorable reimbursement policies.

Sample Request Link: https://www.imarcgroup.com/external-defibrillators-market/requestsample

Market Growth Factors

The global external defibrillators market is significantly driven by the widespread prevalence of out-of-hospital cardiac arrest (OHCA), which is characterized by the loss of mechanical cardiac function and systemic circulation failure, leading to high mortality among adults. This critical health condition necessitates prompt defibrillation, driving demand for external defibrillators worldwide.

Another notable driver is the rising number of individuals with hypertension, diabetes, and obesity linked to unhealthy diets, physical inactivity, and increased tobacco and alcohol consumption. These conditions serve as intermediate risk factors that signal a heightened risk of heart attacks, strokes, and related complications. Primary care facilities often evaluate these risks to provide early intervention, thus boosting the demand for external defibrillators.

Technological advancements have made modern external defibrillators more affordable, user-friendly, and safe, encouraging their adoption across diverse settings. Automated external defibrillators (AEDs), semi-automated, fully automated, and wearable cardioverter defibrillators improve accessibility for users, including laypersons and healthcare professionals. This ease of use alongside rising adoption in public spaces and emergency services positively influences the market growth.

Market Segmentation

Breakup by Product Type:

  • Manual External Defibrillator: Primarily used by healthcare professionals in hospitals and ambulances requiring training to interpret cardiac rhythms and apply proper shock levels.
  • Automated External Defibrillator (AED): Designed for ease of use by laypersons in out-of-hospital emergencies, automatically assessing heart rhythm and delivering shocks if necessary.
  • Wearable Cardioverter Defibrillator: Provides continuous heart monitoring and therapy delivery, used as a temporary solution for high-risk patients ineligible for implantable cardioverter defibrillators.

Breakup by End User:

  • Hospitals: High demand due to frequent cardiac emergencies requiring constant availability of defibrillation equipment.
  • Pre-Hospitals: Increased defibrillator necessity in ambulances and with first responders to improve survival rates in out-of-hospital cardiac arrests.
  • Public Access Market: Driven by government and organizational Public Access Defibrillation (PAD) programs mandating AED installations in public spaces to enhance accessibility.
  • Alternate Care Market: Facilities outside traditional hospitals requiring reliable defibrillators for cardiac care.
  • Home Healthcare: Growing demand for home-use defibrillators as part of managing cardiac emergencies in aging populations.

Regional Insights

North America dominates the global external defibrillators market, attributed to a high prevalence of cardiovascular diseases, growing awareness of sudden cardiac arrest, and widespread adoption of automated external defibrillators (AEDs) in public and healthcare settings. The region benefits from advanced healthcare infrastructure and favorable reimbursement policies that further drive growth. Europe also holds a significant market position, supported by an aging population and government programs promoting AED use in public spaces.

Recent Developments & News

  • April 2024: WEL Medical launched DefibSafe 3 (DS3), a next-gen Automated External Defibrillator storage unit rated IP66 for weather protection.
  • April 2024: Avive Solutions raised $56.5 million in growth equity funding to expand its team and commercial operations.
  • April 2024: The D.C. government initiated a program funding automated external defibrillators in apartment complexes and houses of worship, focusing on African American communities.

Key Players

  • BPL Medical Technologies Private Limited
  • corpuls
  • CU Medical Germany GmbH
  • Defibtech LLC
  • Koninklijke Philips N.V.
  • MEDIANA Co. Ltd.
  • Nihon Kohden Corporation
  • Schiller AG
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Stryker Corporation
  • ZOLL Medical Corporation (Asahi Kasei Corporation)

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Request for customization: https://www.imarcgroup.com/request?type=report&id=5603&flag=E

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201-971-6302